AgeX Therapeutics
ID: 5331654AgeX Therapeutics is a pluripotent stem cell-derived progenitor cell lines founded in 2017 by Michael D. West.
6
Funding Rounds
$163.8m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** D We** | - | - | |
| Mi***** D. We** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** D. We** | - | - | |
| Mi***** Ma* | - | - |
Funding series
Funding Series Analysis
The company AgeX Therapeutics has raised a total of $100m in funding over 6 rounds.
Key Insights:
- AgeX , August 2017: $100m
- AgeX Therapeutics Private equity, September 2018: $43.2m
- AgeX Therapeutics Venture round, August 2018: $5.2m
- AgeX Therapeutics Private equity, June 2018: $5m
- AgeX Therapeutics Grant (money), May 2018: $386k
- AgeX Therapeutics Venture round, August 2017: $10m
Industries
AgeX Therapeutics is active in the following industries: